April 20, 2024
Stocks & Bonds
[STOCK WATCH] Ilyang Pharmaceutical falls 2.28%
[THE INVESTOR] As of Feb. 23 09:40 A.M., Ilyang Pharmaceutical increased 2.28%, compared with yesterday, to 40,400 won. It had increased 8.02% through the past month. Standard deviation, which indicates variableness, records 2.3% over the same period of time over one month.
Compared with its close competitors within the same industry, KOSPI, the monthly earnings rate of Ilyang Pharmaceutical was the highest, while its volatility within 1 month was at a proper rate. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 3.4. Compared with the KOSPI industry, the return-on-risk is much better than the industrial mean, 3.1, and thus the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
Compared with its close competitors within the same industry, KOSPI, the monthly earnings rate of Ilyang Pharmaceutical was the highest, while its volatility within 1 month was at a proper rate. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 3.4. Compared with the KOSPI industry, the return-on-risk is much better than the industrial mean, 3.1, and thus the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
